Education
About Us
Working with TipRanks
Follow Us
Anika Therapeutics (ANIK)
NASDAQ:ANIK
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 119.91M | $ 166.66M | $ 156.24M | $ 147.79M | $ 130.46M |
| Gross Profit | $ 76.00M | $ 103.09M | $ 93.58M | $ 82.94M | $ 69.03M |
| Operating Income | $ -5.10M | $ -87.64M | $ -19.40M | $ -18.48M | $ -14.47M |
| EBITDA | $ -5.10M | $ -11.23M | $ -4.91M | $ 2.62M | $ -12.83M |
| Net Income | $ -56.38M | $ -82.67M | $ -14.86M | $ 4.13M | $ -23.98M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 55.63M | $ 72.87M | $ 86.33M | $ 94.39M | $ 98.32M |
| Total Assets | $ 202.74M | $ 270.63M | $ 349.13M | $ 347.54M | $ 365.61M |
| Total Debt | $ 25.93M | $ 29.04M | $ 30.89M | $ 19.24M | $ 20.88M |
| Net Debt | $ -29.70M | $ -43.83M | $ -55.44M | $ -75.15M | $ -74.94M |
| Total Liabilities | $ 48.75M | $ 58.37M | $ 63.56M | $ 60.45M | $ 93.20M |
| Stockholders' Equity | $ 153.99M | $ 212.26M | $ 285.56M | $ 287.08M | $ 272.40M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.33M | $ -7.21M | $ -3.08M | $ 3.25M | $ 11.44M |
| Operating Cash Flow | $ 5.40M | $ -1.79M | $ 4.41M | $ 8.40M | $ 13.06M |
| Investing Cash Flow | $ -8.33M | $ -5.43M | $ -7.49M | $ -3.12M | $ -71.26M |
| Financing Cash Flow | $ -12.73M | $ -6.32M | $ -4.85M | $ -6.78M | $ -3.77M |